Back to Search
Start Over
Weekly cyclophosphamide, subcutaneous bortezomib and dexamethathasone (CyBorD) for initial treatment of transplant-eligible patients with multiple myeloma: experience of two transplant centres.
- Source :
-
Bone marrow transplantation [Bone Marrow Transplant] 2021 Mar; Vol. 56 (3), pp. 738-740. Date of Electronic Publication: 2020 Oct 19. - Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 1476-5365
- Volume :
- 56
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Bone marrow transplantation
- Publication Type :
- Editorial & Opinion
- Accession number :
- 33077903
- Full Text :
- https://doi.org/10.1038/s41409-020-01086-9